A comparison of the in vitro permeation of 3-O-ethyl-l-ascorbic acid in human skin and in a living skin equivalent (LabSkinâ„¢) / Fotis Iliopoulos in INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, Vol. 43, N° 1 (02/2021)  

[article]  inINTERNATIONAL JOURNAL OF COSMETIC SCIENCE > Vol. 43, N° 1 (02/2021) . - p. 107-112 Titre : A comparison of the in vitro permeation of 3-O-ethyl-l-ascorbic acid in human skin and in a living skin equivalent (LabSkinâ„¢) Type de document : document électronique Auteurs : Fotis Iliopoulos, Auteur ; Alex Chapman, Auteur ; Majella E. Lane, Auteur Année de publication : 2021 Article en page(s) : p. 107-112 Note générale : Bibliogr. Langues : Anglais (eng) Catégories : Barrière cutanée Vitamine C Tags : 'Acide  3-O-éthyl-l-ascorbique'  'Equivalent  peau  humaine'  LabSkin  â„¢  'Barrière  cutanée'  'Livraison  de  la  peau'  Perméation  'Absorption Index. décimale : 668.5 Parfums et cosmétiques Résumé : - Objectives : The safety assessment of personal care products often entails determining dermal absorption of their ingredients. Such experiments are typically performed in human or animal skin in vitro; however, ethical and safety considerations are associated with obtaining these tissues. Several human skin equivalent models (HSEs) have been developed as alternatives to human tissue. The barrier function of such models however, is normally less developed than human skin. Here, we examine the permeability of the HSE LabSkinTM to a model compound, 3-O-ethyl-l-ascorbic acid (EA) compared with human skin. - Methods : Skin uptake and permeation of EA was investigated in vitro using heat-separated human epidermis and LabSkinTM. Finite dose (5 μL cm-2) Franz-diffusion studies were conducted using 2 % (w/w) EA in a ternary solvent mixture comprising propylene glycol (PG), propylene glycol monolaurate (PGML), and isopropyl myristate (IPM). These excipients are commonly used in cosmetic products and they have been reported to promote permeation of EA in a different model, namely porcine skin. - Results : Permeation of EA through LabSkinTM was evident from 2 h ; however, EA permeation in human skin was not detected until 5 h. Similar amounts of EA permeated through the two membranes at time points 8, 10, 12 and 24 h (p > 0.05). The cumulative amounts of EA delivered through LabSkinTM at 24 h were 41.3 ± 2.0 µg cm−2, corresponding to 55.1 ± 1.8 % of the applied dose. Similar amounts permeated across human skin, 49.4 ± 4.1 µg cm−2, accounting for 58.0 ± 4.2 % of the dose applied (p > 0.05). - Conclusion : The permeation of EA in LabSkinTM compared well with results for human epidermis in terms of the permeation profiles and the cumulative amounts of EA that permeated. The data suggest that the skin barrier of the two models was similar with regard to their overall permeability to the hydrophilic active EA. The findings are promising for the use of LabSkinTM as a surrogate for human skin in permeability testing. Future studies will focus on exploring the reproducibility and robustness of LabSkinTM for delivery of other actives that span a range of physicochemical properties. DOI : https://doi.org/10.1111/ics.12675 En ligne : https://drive.google.com/file/d/18D4sVi7kxi_s1HySIKy3cou71CIz_-RM/view?usp=shari [...] Format de la ressource électronique : Pdf Permalink : https://e-campus.itech.fr/pmb/opac_css/index.php?lvl=notice_display&id=35449 [article]

Exemplaires

Code-barres	Cote	Support	Localisation	Section	Disponibilité
aucun exemplaire

---

1 (1 - 1 / 1)